Atlas Trials

A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer

Clinical trial NCT03520478 · UNKNOWN

Trial details

NCT number
NCT03520478
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate CancerHormone-Dependent Prostate Cancer
Start date
2018-05-30
Primary completion
2023-04-30
Enrollment
654

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.